[Gastric carcinoma. Our experience].
This study analysed 66 cases of gastric cancer from 1985 to 1992. Twenty-seven patients (41%) has been treated with anti-H2 drug, either medical care or Jerkily "a la demande": 12 patients have been treated several years. Of the 66 patients: 52 (89%) were operated on while the other 16 received medical treatment because of the extension disease and their precarious condition. Long-term 35 (67%) patients (of the 52 operated) died four years later, independently of the stage and PKT of the first and the second level. The 27 patients treated with anti-H2 drug showed the most undifferentiated grading and 88% belong to the third and the fourth stage; moreover 81% underwent first diagnostic endoscopy notwithstanding a clinical and surgical history of gastric ulcer. Is it possible, therefore, that anti-H2 drug delay the diagnosis.
Bianchi
R
R
Istituto di Chirurgia d'Urgenza, Università degli Studi di Torino.
Galasso
F
F
Urban
I
I
Unio
R
R
Graziano
L
L
Foco
A
A
Bertoldo
U
U
Orlando
E
E
Rozzio
G
G
Vigezzi
P A
PA
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*
Il carcinoma gastrico. Nostra esperienza.